Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.

Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS

Open access

Published version of a preprint

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are two incurable neurodegenerative disorders that exist on a symptomological spectrum and share both genetic underpinnings and pathophysiological hallmarks. Functional abnormality of TAR DNA-binding protein 43 (TDP-43), an aggregation-prone RNA and DNA binding protein, is observed in the vast majority of both familial and sporadic ALS cases and in ~40% of FTLD cases, but the cascade of events leading to cell death are not understood. We have expressed human TDP-43 (hTDP-43) in Drosophila neurons and glia, a model that recapitulates many of the characteristics of TDP-43-linked human disease including protein aggregation pathology, locomotor impairment, and premature death. We report that such expression of hTDP-43 impairs small interfering RNA (siRNA) silencing, which is the major post-transcriptional mechanism of retrotransposable element (RTE) control in somatic tissue. This is accompanied by de-repression of a panel of both LINE and LTR families of RTEs, with somewhat different elements being active in response to hTDP-43 expression in glia versus neurons. hTDP-43 expression in glia causes an early and severe loss of control of a specific RTE, the endogenous retrovirus (ERV) gypsy. We demonstrate that gypsy causes the degenerative phenotypes in these flies because we are able to rescue the toxicity of glial hTDP-43 either by genetically blocking expression of this RTE or by pharmacologically inhibiting RTE reverse transcriptase activity. Moreover, we provide evidence that activation of DNA damage-mediated programmed cell death underlies both neuronal and glial hTDP-43 toxicity, consistent with RTE-mediated effects in both cell types. Our findings suggest a novel mechanism in which RTE activity contributes to neurodegeneration in TDP-43-mediated diseases such as ALS and FTLD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1006635

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Neuronal and glial hTDP-43 expression results in induction of RTE expression. Differential expression of many genes and RTEs are detected in response to either neuronal or glial expression of hTDP-43 in head tissue of 8–10 day old flies (N = 2 biological replicates per genotype). (A) Neuronal (Elav > hTDP-43) expression of hTDP-43 results in both increases and decreases in expression of a broad variety of cellular transcripts (See S2A Table). (B) A panel of transposons, including many RTEs, also are impacted, with most exhibiting elevated expression (See S2B Table). (C) Glial expression of hTDP-43 (Repo > hTDP-43) also results in numerous transcriptome alterations, with many transcripts either increasing or decreasing in abundance (See S3A Table). (D) Many transposons, most of which are RTEs, exhibit elevated expression levels in response to glial hTDP-43 expression (See S3B Table). Several RTEs display elevated expression in response to both glial and neuronal hTDP-43 expression, however a number also exhibit specificity in response to either glial or neuronal hTDP-43 expression (compare Fig 1B and 1D). (E) The gypsy ERV exhibits elevated expression only in response to glial, but not neuronal, hTDP-43 expression. See methods for details regarding analysis pipeline, including statistical analysis.
Fig 1 Neuronal and glial hTDP-43 expression results in induction of RTE expression. Differential expression of many genes and RTEs are detected in response to either neuronal or glial expression of hTDP-43 in head tissue of 8–10 day old flies (N = 2 biological replicates per genotype). (A) Neuronal (Elav > hTDP-43) expression of hTDP-43 results in both increases and decreases in expression of a broad variety of cellular transcripts (See S2A Table). (B) A panel of transposons, including many RTEs, also are impacted, with most exhibiting elevated expression (See S2B Table). (C) Glial expression of hTDP-43 (Repo > hTDP-43) also results in numerous transcriptome alterations, with many transcripts either increasing or decreasing in abundance (See S3A Table). (D) Many transposons, most of which are RTEs, exhibit elevated expression levels in response to glial hTDP-43 expression (See S3B Table). Several RTEs display elevated expression in response to both glial and neuronal hTDP-43 expression, however a number also exhibit specificity in response to either glial or neuronal hTDP-43 expression (compare Fig 1B and 1D). (E) The gypsy ERV exhibits elevated expression only in response to glial, but not neuronal, hTDP-43 expression. See methods for details regarding analysis pipeline, including statistical analysis.CC BY · PubMed Central
Fig 2 Glial hTDP-43 expression results in early and dramatic de-suppression of the gypsy ERV. (A) Transcript levels of gypsy ORF2 (Pol) as detected by qPCR in whole head tissue of flies expressing hTDP-43 in neurons (ELAV > hTDP-43) versus glia (Repo > hTDP-43) at a young (2–4 Day) or aged (8–10 Day) time point. Transcript levels normalized to Actin and displayed as fold change relative to flies carrying the hTDP-43 transgene with no Gal4 driver (hTDP-43 / +) at 2–4 Days (means + SEM). A two-way ANOVA reveals a significant effect of genotype (p < 0.0001) but no effect of age (p = 0.5414). N = 8 for all groups. (B) An equivalent analysis shows that gypsy ORF3 (Env) likewise displays a significant effect of genotype (p < 0.0001) and no effect of age (p = 0.6530). N = 4 for the 2–4 Day cohort and N = 5 for the 8–10 Day cohort. (C) Central projections of whole mount brains immunostained with a monoclonal antibody directed against gypsy ENV protein reveals dramatic, early accumulation of ENV immunoreactive puncta in brains expressing glial hTDP-43 (5–8 Days) in comparison to both age-matched genetic controls (ELAV / +; Repo / +; hTDP-43 / +) and flies expressing neuronal hTDP-43. This effect persists out to 19–25 Days post-eclosion. ELAV / +, 5–8 Day (N = 3), 19–25 Day (N = 4); Repo / +, 5–8 Day (N = 3), 19–25 Day (N = 3); hTDP-43 / +, 5–8 Day (N = 5), 19–25 Day (N = 2); ELAV > hTDP-43, 5–8 Day (N = 2), 19–25 Day (N = 4); Repo > hTDP-43, 5–8 Day (N = 7), 19–25 Day (N = 8).
Fig 2 Glial hTDP-43 expression results in early and dramatic de-suppression of the gypsy ERV. (A) Transcript levels of gypsy ORF2 (Pol) as detected by qPCR in whole head tissue of flies expressing hTDP-43 in neurons (ELAV > hTDP-43) versus glia (Repo > hTDP-43) at a young (2–4 Day) or aged (8–10 Day) time point. Transcript levels normalized to Actin and displayed as fold change relative to flies carrying the hTDP-43 transgene with no Gal4 driver (hTDP-43 / +) at 2–4 Days (means + SEM). A two-way ANOVA reveals a significant effect of genotype (p < 0.0001) but no effect of age (p = 0.5414). N = 8 for all groups. (B) An equivalent analysis shows that gypsy ORF3 (Env) likewise displays a significant effect of genotype (p < 0.0001) and no effect of age (p = 0.6530). N = 4 for the 2–4 Day cohort and N = 5 for the 8–10 Day cohort. (C) Central projections of whole mount brains immunostained with a monoclonal antibody directed against gypsy ENV protein reveals dramatic, early accumulation of ENV immunoreactive puncta in brains expressing glial hTDP-43 (5–8 Days) in comparison to both age-matched genetic controls (ELAV / +; Repo / +; hTDP-43 / +) and flies expressing neuronal hTDP-43. This effect persists out to 19–25 Days post-eclosion. ELAV / +, 5–8 Day (N = 3), 19–25 Day (N = 4); Repo / +, 5–8 Day (N = 3), 19–25 Day (N = 3); hTDP-43 / +, 5–8 Day (N = 5), 19–25 Day (N = 2); ELAV > hTDP-43, 5–8 Day (N = 2), 19–25 Day (N = 4); Repo > hTDP-43, 5–8 Day (N = 7), 19–25 Day (N = 8).CC BY · PubMed Central
Fig 3 Neuronal and glial hTDP-43 expression induces physiological impairment and toxicity with varying severity. (A) Flies expressing glial hTDP-43 display extreme locomotor impairment at 1–5 days post-eclosion in the Benzer fast phototaxis assay, while flies expressing neuronal hTDP-43 demonstrate a slight locomotor deficit in comparison to genetic controls (one-way ANOVA, p < 0.0001). This trend continues and is exacerbated by 5–10 days post-eclosion (one-way ANOVA, p < 0.0001). Four biological replicates performed for each experiment. (B) Lifespan analysis of flies expressing neuronal versus glial hTDP-43 in comparison to genetic controls. (C) Central projections of whole-mount brains reveals a stark increase in TUNEL-positive cells in flies expressing glial hTDP-43 in comparison to genetic controls at 5 days post-eclosion. N = 16 for Repo / + and N = 18 for Repo > hTDP-43. (D) TEM likewise reveals rampant apoptosis in the neuropil of flies expressing glial hTDP-43 at 12 days post-eclosion. Arrowheads indicate pro-apoptotic nuclei, as identified by morphology.
Fig 3 Neuronal and glial hTDP-43 expression induces physiological impairment and toxicity with varying severity. (A) Flies expressing glial hTDP-43 display extreme locomotor impairment at 1–5 days post-eclosion in the Benzer fast phototaxis assay, while flies expressing neuronal hTDP-43 demonstrate a slight locomotor deficit in comparison to genetic controls (one-way ANOVA, p < 0.0001). This trend continues and is exacerbated by 5–10 days post-eclosion (one-way ANOVA, p < 0.0001). Four biological replicates performed for each experiment. (B) Lifespan analysis of flies expressing neuronal versus glial hTDP-43 in comparison to genetic controls. (C) Central projections of whole-mount brains reveals a stark increase in TUNEL-positive cells in flies expressing glial hTDP-43 in comparison to genetic controls at 5 days post-eclosion. N = 16 for Repo / + and N = 18 for Repo > hTDP-43. (D) TEM likewise reveals rampant apoptosis in the neuropil of flies expressing glial hTDP-43 at 12 days post-eclosion. Arrowheads indicate pro-apoptotic nuclei, as identified by morphology.CC BY · PubMed Central
Fig 4 gypsy ERV expression contributes to hTDP-43 mediated toxicity. (A) Lifespan analysis shows that co-expression of gypsy(IR) (Repo > gypsy(IR) + hTDP-43) partially rescues the lifespan deficit exhibited by flies expressing glial hTDP-43 (Repo > hTDP-43). (B) Co-expression of an unrelated GFP(IR) control transgene (Repo > GFP(IR) + hTDP-43) does not effect the lifespan of flies expressing glial hTDP-43 (Repo > hTDP-43). (C) Co-expression of gypsy(IR) (ELAV > gypsy(IR) + hTDP-43) has no effect on lifespan in flies expressing neuronal hTDP-43 (ELAV > hTDP-43).
Fig 4 gypsy ERV expression contributes to hTDP-43 mediated toxicity. (A) Lifespan analysis shows that co-expression of gypsy(IR) (Repo > gypsy(IR) + hTDP-43) partially rescues the lifespan deficit exhibited by flies expressing glial hTDP-43 (Repo > hTDP-43). (B) Co-expression of an unrelated GFP(IR) control transgene (Repo > GFP(IR) + hTDP-43) does not effect the lifespan of flies expressing glial hTDP-43 (Repo > hTDP-43). (C) Co-expression of gypsy(IR) (ELAV > gypsy(IR) + hTDP-43) has no effect on lifespan in flies expressing neuronal hTDP-43 (ELAV > hTDP-43).CC BY · PubMed Central
Fig 5 DNA damage-induced cell death and gypsy ERV expression contribute hTDP-43 mediated toxicity. (A) Lifespan analysis shows that co-expression of loki(IR) (Repo > loki(IR) + hTDP-43) fully rescues the lifespan deficit exhibited by flies expressing glial hTDP-43 (Repo > hTDP-43). (B) Co-expression of loki(IR) (ELAV > loki(IR) + hTDP-43) likewise fully rescues the lifespan deficit exhibited by flies expressing neuronal hTDP-43 (ELAV > hTDP-43). (C) Central projections of whole-mount TUNEL stained brains reveal a noticeable reduction in the apoptotic activity induced by glial hTDP-43 expression (Repo > hTDP-43 + GFP(IR)) when gypsy expression is knocked down (Repo > hTDP-43 + gypsy(IR)), while knocking down loki completely alleviates the apoptosis induced by glial hTDP-43 expression (Repo > hTDP-43 + loki(IR)). (D) Quantification of (H), normalized to the positive control (Repo > hTDP-43 + GFP(IR)). N = 12 for Repo / +; N = 9 for Repo > hTDP-43 + GFP(IR); N = 7 for Repo > hTDP-43 + gypsy(IR); and N = 7 for Repo > hTDP-43 + loki(IR). *All of the lifespans with the exception of the NRTI feeding experiments shown in Figs 4 and 5, were performed concurrently in order to ensure comparability across groups. Therefore, appropriate controls are shared across panels.
Fig 5 DNA damage-induced cell death and gypsy ERV expression contribute hTDP-43 mediated toxicity. (A) Lifespan analysis shows that co-expression of loki(IR) (Repo > loki(IR) + hTDP-43) fully rescues the lifespan deficit exhibited by flies expressing glial hTDP-43 (Repo > hTDP-43). (B) Co-expression of loki(IR) (ELAV > loki(IR) + hTDP-43) likewise fully rescues the lifespan deficit exhibited by flies expressing neuronal hTDP-43 (ELAV > hTDP-43). (C) Central projections of whole-mount TUNEL stained brains reveal a noticeable reduction in the apoptotic activity induced by glial hTDP-43 expression (Repo > hTDP-43 + GFP(IR)) when gypsy expression is knocked down (Repo > hTDP-43 + gypsy(IR)), while knocking down loki completely alleviates the apoptosis induced by glial hTDP-43 expression (Repo > hTDP-43 + loki(IR)). (D) Quantification of (H), normalized to the positive control (Repo > hTDP-43 + GFP(IR)). N = 12 for Repo / +; N = 9 for Repo > hTDP-43 + GFP(IR); N = 7 for Repo > hTDP-43 + gypsy(IR); and N = 7 for Repo > hTDP-43 + loki(IR). *All of the lifespans with the exception of the NRTI feeding experiments shown in Figs 4 and 5, were performed concurrently in order to ensure comparability across groups. Therefore, appropriate controls are shared across panels.CC BY · PubMed Central
Fig 6 Glial and neuronal hTDP-43 expression erodes siRNA-mediated silencing. (A) Representative central projections show that co-expression of the hTDP-43 transgene, but not an unrelated tdTomato control transgene, interferes with the ability of a Dcr-2 processed IR (GFP(IR)) to silence a GFP transgenic reporter in glial cells using the Repo-GAL4 driver. Quantification of GFP signal for each group is shown in the appropriate bar graph; values are represented as relative fold change over Repo > GFP + GFP(IR) (mean + SEM). A two-way ANOVA reveals significant effects of both genotype (p < 0.0001) and age (p < 0.0001), and a significant age x genotype interaction (p < 0.0001). N = 5 for Repo > GFP and Repo > GFP + GFP(IR); N = 10 for all other groups. (B) An equivalent analysis demonstrates that hTDP-43 has a similar effect in the neuronal cells of the Drosophila mushroom body using the OK107-Gal4 driver, but with a later age of onset than hTDP-43 expression in glial cells. Quantification of GFP signal for each group is shown in the appropriate bar graph as in (A). A two-way ANOVA reveals significant effects of genotype (p = 0.0054) and age (p < 0.0001), as well as a significant age x genotype interaction (p = 0.0021). N = 5 for OK107 > GFP and OK107 > GFP + GFP(IR); N = 10 for all other groups. (C) Co-expression of hTDP-43, but not GFP, in the photoreceptor neurons of the fly eye under the GMR-Gal4 driver interrupts the ability of a Dcr-2 processed IR to silence the endogenous white+ pigment gene with an age of onset similar to that observed with neuronal expression of hTDP-43 in the CNS under OK107-Gal4, resulting in characteristic clusters of red-pigmented ommatidia. N = 5 for GMR > w(IR) + Gal80ts OFF and GMR > w(IR) + Gal80ts ON; N = 20 for all other groups.
Fig 6 Glial and neuronal hTDP-43 expression erodes siRNA-mediated silencing. (A) Representative central projections show that co-expression of the hTDP-43 transgene, but not an unrelated tdTomato control transgene, interferes with the ability of a Dcr-2 processed IR (GFP(IR)) to silence a GFP transgenic reporter in glial cells using the Repo-GAL4 driver. Quantification of GFP signal for each group is shown in the appropriate bar graph; values are represented as relative fold change over Repo > GFP + GFP(IR) (mean + SEM). A two-way ANOVA reveals significant effects of both genotype (p < 0.0001) and age (p < 0.0001), and a significant age x genotype interaction (p < 0.0001). N = 5 for Repo > GFP and Repo > GFP + GFP(IR); N = 10 for all other groups. (B) An equivalent analysis demonstrates that hTDP-43 has a similar effect in the neuronal cells of the Drosophila mushroom body using the OK107-Gal4 driver, but with a later age of onset than hTDP-43 expression in glial cells. Quantification of GFP signal for each group is shown in the appropriate bar graph as in (A). A two-way ANOVA reveals significant effects of genotype (p = 0.0054) and age (p < 0.0001), as well as a significant age x genotype interaction (p = 0.0021). N = 5 for OK107 > GFP and OK107 > GFP + GFP(IR); N = 10 for all other groups. (C) Co-expression of hTDP-43, but not GFP, in the photoreceptor neurons of the fly eye under the GMR-Gal4 driver interrupts the ability of a Dcr-2 processed IR to silence the endogenous white+ pigment gene with an age of onset similar to that observed with neuronal expression of hTDP-43 in the CNS under OK107-Gal4, resulting in characteristic clusters of red-pigmented ommatidia. N = 5 for GMR > w(IR) + Gal80ts OFF and GMR > w(IR) + Gal80ts ON; N = 20 for all other groups.CC BY · PubMed Central
Fig 7 A cellular model for RTE mediated DNA damage and apoptotic cell death in TDP-43 pathology. In a healthy cell TDP-43 protein is predominantly found in the nucleus with the capacity to shuttle between the nucleus and the cytoplasm. This pleiotropic protein plays many important roles in normal RNA metabolism in both cellular compartments (A). Cells that experience TDP-43 pathology exhibit accumulation of TDP-43 protein in dense cytoplasmic inclusions and clearance from the nucleus (B). This is accompanied by rapid deterioration of siRNA-mediated silencing, as well as activation of RTE expression (C). The apoptotic cell death (F) induced by TDP-43 pathology is largely mediated by Loki/Chk-2 signaling (E). In the case of hTDP-43 pathology in fly glial cells in the CNS, expression of the gypsy RTE contributes to hTDP-43-induced cell death. Based on this observation, as well as the known cell biological role of Loki/Chk-2, we infer that the apoptosis induced by TDP-43 pathology is largely the result of Chk-2 activation in response to TDP-43-induced DNA damage (D), and that this DNA damage is at least partially incurred by TDP-43’s effects on RTEs (C).
Fig 7 A cellular model for RTE mediated DNA damage and apoptotic cell death in TDP-43 pathology. In a healthy cell TDP-43 protein is predominantly found in the nucleus with the capacity to shuttle between the nucleus and the cytoplasm. This pleiotropic protein plays many important roles in normal RNA metabolism in both cellular compartments (A). Cells that experience TDP-43 pathology exhibit accumulation of TDP-43 protein in dense cytoplasmic inclusions and clearance from the nucleus (B). This is accompanied by rapid deterioration of siRNA-mediated silencing, as well as activation of RTE expression (C). The apoptotic cell death (F) induced by TDP-43 pathology is largely mediated by Loki/Chk-2 signaling (E). In the case of hTDP-43 pathology in fly glial cells in the CNS, expression of the gypsy RTE contributes to hTDP-43-induced cell death. Based on this observation, as well as the known cell biological role of Loki/Chk-2, we infer that the apoptosis induced by TDP-43 pathology is largely the result of Chk-2 activation in response to TDP-43-induced DNA damage (D), and that this DNA damage is at least partially incurred by TDP-43’s effects on RTEs (C).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 120 references

Cited by

See all 201

Metadata

Authors
Krug, L., Chatterjee, N., Borges-Monroy, R., Hearn, S., Liao, W.-W., Morrill, K., Prazak, L., Rozhkov, N., Theodorou, D., Hammell, M., & Dubnau, J.
Affiliations
  • Cold Spring Harbor Laboratory (US)
  • Farmingdale State College (US)
Corresponding author
  • Krug, Lisa
  • Chatterjee, Nabanita
  • Borges-Monroy, Rebeca
  • Hearn, Stephen
  • Liao, Wen-Wei
  • Morrill, Kathleen
  • Prazak, Lisa
  • Rozhkov, Nikolay
  • Theodorou, Delphine
Venue
PLOS Genetics
Published
2017-03-16
Volume
13
Issue
3
Pages
e1006635
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W2952199982
Cited by
201
References
120
Citations by year
2026: 12 · 2025: 16 · 2024: 24 · 2023: 16 · 2022: 19 · 2021: 29 · 2020: 31 · 2019: 26 · 2018: 22 · 2017: 6
FWCI
16.18
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • SUNY Digital Repository Support (State University of New York System) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institute of Neurological Disorders and Stroke (NS067690, NS091748)
  • DART Neuroscience LLC
  • Ride For Life
  • Rita Allen Foundation
  • National Institutes of Health (T32GM065094)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
amyotrophic lateral sclerosis, frontotemporal lobar degeneration, TDP-43, retrotransposons, transposable elements, line element, LTR retrotransposons, siRNA knockdown, RNA interference, neurodegeneration, programmed cell death, DNA damage, reverse transcriptase inhibition, Drosophila model
MeSH terms
Amyotrophic Lateral Sclerosis, Animals, Disease Models, Animal, DNA-Binding Proteins, Drosophila melanogaster, Humans, Immunohistochemistry, Male, Neuroglia, Neurons, Microscopy, Confocal, Retroelements, Neurodegenerative Diseases, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Animals, Genetically Modified, RNA Interference, Microscopy, Electron, Transmission, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. https://app.cochat.ai/papers/10.1371/journal.pgen.1006635
The paper
Krug, L., Chatterjee, N., Borges-Monroy, R., Hearn, S., Liao, W.-W., Morrill, K., Prazak, L., Rozhkov, N., Theodorou, D., Hammell, M., & Dubnau, J. (2017). Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1006635

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.